Status:
COMPLETED
Treating Smokers With Mental Illness
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
Hennepin County Medical Center, Minneapolis
Brown University
Conditions:
Smoking Cessation
Cigarette Smoking
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This is a smoking cessation study that will enroll smokers who have been diagnosed with a severe mental illness. The study will use a combination of intensive tobacco treatment counseling and nicotine...
Detailed Description
At the baseline measurement visit, participants will be asked to complete a survey and an interview. They will be randomly assigned to either the intervention or control group. Both groups will receiv...
Eligibility Criteria
Inclusion
- have a severe mental illness diagnosis
- be a daily smoker
- be willing to reduce the number of cigarettes smoked per day leading to a quit attempt
- want to try to quit smoking
- be willing to use nicotine replacement therapy
- be able to communicate in English
Exclusion
- anyone who has had an active psychotic episode or been hospitalized due to suicidal ideation in the last six months
- pregnancy
- taking Chantix or Clozapine
- having a terminal illness
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2020
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03822416
Start Date
March 1 2019
End Date
May 4 2020
Last Update
May 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455